SCHEMBL6182

SCHEMBL6182

O=C(O)Cc1ccc(COc2ccccc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 6/20 0.69
FFAR4 Q5NUL3 2/20 0.62
ALOX5 P09917 2/20 0.61
ALDH1A1 P00352 1/20 0.60
MAPT P10636 1/20 0.60
AKR1B1 P15121 1/20 0.59
APP P05067 1/20 0.58
NR4A1 P22736 1/20 0.58
NR4A2 P43354 1/20 0.58
NR4A3 Q92570 1/20 0.58
SRD5A2 P31213 1/20 0.57
MEN1 O00255 1/20 0.57
NPC1 O15118 1/20 0.57
RAB9A P51151 1/20 0.57
KMT2A Q03164 1/20 0.57
RXFP1 Q9HBX9 1/20 0.57
ABCC4 O15439 1/20 0.57
LMNA P02545 1/20 0.57
GAA P10253 1/20 0.57
TSHR P16473 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1066614 0.94 FFAR1 (0.70) FFAR1FFAR4ALOX5AKR1B1NR4A1
Hydrochloric Acid SCHEMBL10622121 0.93 FFAR1 (0.68) FFAR1FFAR4ALOX5AKR1B1NR4A1
SCHEMBL4222632 0.93 FFAR1 (0.68) FFAR1FFAR4ALOX5AKR1B1NR4A1
Ammonia Solution, Strong SCHEMBL27788257 0.93 FFAR1 (0.68) FFAR1FFAR4ALOX5AKR1B1NR4A1
SCHEMBL1756380 0.90 FFAR1 (0.72) FFAR1FFAR4ALOX5AKR1B1NR4A1
SCHEMBL5205577 0.90 FFAR1 (0.72) FFAR1FFAR4ALOX5AKR1B1NR4A1
SCHEMBL6341082 0.90 FFAR1 (0.68) FFAR1FFAR4ALOX5AKR1B1NR4A1
SCHEMBL6238323 0.87 ALDH1A1 (0.73) FFAR1FFAR4ALOX5ALDH1A1MAPT
SCHEMBL9659998 0.84 FFAR1 (0.71) FFAR1FFAR4ALOX5APPSRD5A2
SCHEMBL3498840 0.84 NR4A2 (0.71) FFAR1APPNR4A2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115427409-B Pyrimidine-4 (3H) -one derivatives as TRPV4 antagonists 拉夸里亚创药株式会社 2025-02-25 CN disclosed
CN-115427409-A Pyrimidin-4 (3H) -one derivatives as TRPV4 antagonists 拉夸里亚创药株式会社 2022-12-02 CN disclosed
CN-110407727-B Method for preparing alkyl trifluoromethyl selenide 武汉理工大学 2020-07-31 CN disclosed
CN-110407727-A A method of preparing alkyl trifluoromethyl selenide UNIV WUHAN TECH 2019-11-05 CN disclosed
US-20140364398-A1 C-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents PFIZER INC. (US) 2014-12-11 US disclosed
US-8853258-B2 C-linked hydroxamic acid derivatives useful as antibacterial agents PFIZER INC. (US) 2014-10-07 US disclosed
EP-2488489-A2 C-LINKED HYDROXAMIC ACID DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS Pfizer Inc. (US) 2012-08-22 EP disclosed
US-20120202777-A1 C-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents BROWN MATTHEW FRANK (US) 2012-08-09 US disclosed
WO-2011045703-A2 C-LINKED HYDROXAMIC ACID DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS PFIZER INC. (US) 2011-04-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202777-A1 C-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents HAX1, LPXN, AGXT FFAR1 1313/4885FFAR4 2386/4885ALOX5 653/4885
US-20140364398-A1 C-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents LCT, AGXT, PRXL2A FFAR1 2319/4885FFAR4 2899/4885ALOX5 525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.